chr17-81906878-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_002861.5(PCYT2):c.558C>T(p.Pro186Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00383 in 1,613,116 control chromosomes in the GnomAD database, including 199 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.020 ( 102 hom., cov: 33)
Exomes 𝑓: 0.0021 ( 97 hom. )
Consequence
PCYT2
NM_002861.5 synonymous
NM_002861.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.547
Publications
0 publications found
Genes affected
PCYT2 (HGNC:8756): (phosphate cytidylyltransferase 2, ethanolamine) This gene encodes an enzyme that catalyzes the formation of CDP-ethanolamine from CTP and phosphoethanolamine in the Kennedy pathway of phospholipid synthesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
PCYT2 Gene-Disease associations (from GenCC):
- spastic paraplegia 82, autosomal recessiveInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 17-81906878-G-A is Benign according to our data. Variant chr17-81906878-G-A is described in ClinVar as Benign. ClinVar VariationId is 777258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.547 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0671 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0201 AC: 3063AN: 152204Hom.: 101 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
3063
AN:
152204
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00516 AC: 1291AN: 250418 AF XY: 0.00406 show subpopulations
GnomAD2 exomes
AF:
AC:
1291
AN:
250418
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00212 AC: 3103AN: 1460794Hom.: 97 Cov.: 33 AF XY: 0.00183 AC XY: 1333AN XY: 726702 show subpopulations
GnomAD4 exome
AF:
AC:
3103
AN:
1460794
Hom.:
Cov.:
33
AF XY:
AC XY:
1333
AN XY:
726702
show subpopulations
African (AFR)
AF:
AC:
2474
AN:
33478
American (AMR)
AF:
AC:
151
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
AC:
55
AN:
26118
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
9
AN:
86254
European-Finnish (FIN)
AF:
AC:
0
AN:
52490
Middle Eastern (MID)
AF:
AC:
15
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
140
AN:
1111910
Other (OTH)
AF:
AC:
259
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
171
342
512
683
854
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0201 AC: 3069AN: 152322Hom.: 102 Cov.: 33 AF XY: 0.0195 AC XY: 1454AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
3069
AN:
152322
Hom.:
Cov.:
33
AF XY:
AC XY:
1454
AN XY:
74490
show subpopulations
African (AFR)
AF:
AC:
2877
AN:
41554
American (AMR)
AF:
AC:
135
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
15
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
AC:
16
AN:
68022
Other (OTH)
AF:
AC:
20
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
147
294
441
588
735
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
May 06, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 20, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.